Tin tức & Cập nhật

The third-generation human epidermal growth factor receptor 2 (HER2)-directed antibody‒drug conjugate (ADC) SHR-A1811 has passed its phase II trial, demonstrating safety and efficacy in the neoadjuvant setting for patients with HER2-positive breast cancer.

A retrospective cohort study presented at AAN 2025 has demonstrated that prophylactic zonisamide can significantly reduce headache days per month (HDPM) in paediatric patients with migraine.

In a study presented at EASL 2025, the use of statins appears to be associated with a reduced risk of hepatocellular carcinoma (HCC) and slower progression of liver fibrosis in individuals with chronic liver disease (CLD).